AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18071022 — intervention group
Group type: EXPERIMENTAL
Intervention: Cough Quality of Life Questionnaire (CQLQ)
Number of subjects: 147
Study 18071022 — intervention group
Group type: EXPERIMENTAL
Intervention: CQLQ
Number of subjects: 147
Study 18071022 — intervention group
Group type: EXPERIMENTAL
Intervention: Generic health status measure (EuroQol)
Number of subjects: 147
Study 18071022 — intervention group
Group type: EXPERIMENTAL
Intervention: CQLQ and LCQ correlation
Number of subjects: 147
Study 18071022 — intervention group
Group type: EXPERIMENTAL
Intervention: EuroQol visual analog scale
Number of subjects: 147
Study 16788683 — intervention group
Group type: EXPERIMENTAL
Intervention: COBAS Amplicor CMV Monitor (CACM)
Number of subjects: 72
Study 16788683 — intervention group
Group type: COMPARATOR
Intervention: In-house PCR assay
Number of subjects: 72
Study 16788683 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients developing HCMV disease
Number of subjects: 72
Study 16788683 — intervention group
Group type: EXPERIMENTAL
Intervention: Seropositive patients receiving a seronegative graft
Number of subjects: 72
Study 16788683 — intervention group
Group type: EXPERIMENTAL
Intervention: HCMV infection
Number of subjects: 72
Study 15648589 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocolloid application
Number of subjects: 0
Study 15648589 — intervention group
Group type: COMPARATOR
Intervention: Guideline application
Number of subjects: 0
Study 11084571 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex cysts (characteristics: septum, solid component, irregular or thick wall)
Number of subjects: 20000
Study 11084571 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term oral contraceptive use
Number of subjects: 20000
Study 11084571 — intervention group
Group type: EXPERIMENTAL
Intervention: Family history of ovarian cancer or multiple breast cancers
Number of subjects: 20000
Study 11084571 — intervention group
Group type: EXPERIMENTAL
Intervention: Other abnormalities (including simple cysts, bilateral cysts, or all abnormalities combined)
Number of subjects: 20000
Study 9260370 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiotherapy (HFT) - 81.6 Gy/68 fractions in 7 weeks
Number of subjects: 68
Study 9260370 — intervention group
Group type: EXPERIMENTAL
Intervention: Concomitant boost radiotherapy (CBT) - 72.3 Gy/42 fractions in 6 weeks
Number of subjects: 68
Study 9260370 — intervention group
Group type: EXPERIMENTAL
Intervention: HFT
Number of subjects: 68
Study 9260370 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT
Number of subjects: 68
Study 9260370 — intervention group
Group type: EXPERIMENTAL
Intervention: HFT and CBT
Number of subjects: 68
Study 7691013 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible cystoscopy
Number of subjects: 101
Study 7691013 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid cystoscopy
Number of subjects: 101
Study 7691013 — intervention group
Group type: COMPARATOR
Intervention: Control group (no cystoscopy)
Number of subjects: 101
Study 7691013 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate biopsy
Number of subjects: 101
Study 7691013 — intervention group
Group type: EXPERIMENTAL
Intervention: TURP
Number of subjects: 101
Study 3575603 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol
Number of subjects: 12
Study 3575603 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 12
Study 3575603 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 12
Study 30144429 — intervention group
Group type: EXPERIMENTAL
Intervention: Obeticholic Acid (OCA) 5, 10, or 25 mg/d for 17 days
Number of subjects: 24
Study 30144429 — intervention group
Group type: EXPERIMENTAL
Intervention: Obeticholic Acid (OCA) 10 mg/kg for 2 weeks in mice
Number of subjects: 24
Study 30144429 — intervention group
Group type: COMPARATOR
Intervention: Water or vehicle (control) in mice
Number of subjects: 24
Study 26563519 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical recombinant human epidermal growth factor (EGF) cream
Number of subjects: 80
Study 26563519 — intervention group
Group type: COMPARATOR
Intervention: Vehicle without EGF
Number of subjects: 80
Study 26563519 — intervention group
Group type: EXPERIMENTAL
Intervention: Four additional therapeutic moisturizers
Number of subjects: 80
Study 24912060 — intervention group
Group type: EXPERIMENTAL
Intervention: Supported Employment
Number of subjects: 64
Study 24912060 — intervention group
Group type: COMPARATOR
Intervention: Standard Vocational Rehabilitation Services
Number of subjects: 64
Study 24912060 — intervention group
Group type: COMPARATOR
Intervention: Psychosocial Clubhouse Program
Number of subjects: 64
Study 22284328 — intervention group
Group type: EXPERIMENTAL
Intervention: Cre8 stents
Number of subjects: 323
Study 22284328 — intervention group
Group type: COMPARATOR
Intervention: Taxus Liberté stents
Number of subjects: 323
Study 22284328 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 323
Study 20206924 — intervention group
Group type: EXPERIMENTAL
Intervention: Processing information in terms of its relevance to fitness-based scenarios in an ancestral environment (the grasslands)
Number of subjects: 0
Study 20206924 — intervention group
Group type: COMPARATOR
Intervention: Processing information in terms of its relevance to fitness-based scenarios in a modern urban environment (a city)
Number of subjects: 0
Study 17955457 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) treatment
Number of subjects: 42
Study 16840798 — intervention group
Group type: EXPERIMENTAL
Intervention: Pre-ovarian block (POB)
Number of subjects: 183
Study 12722031 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose prednisolone therapy (initial dose of 20 mg/d, tapered to 5 mg/d over 2 years)
Number of subjects: 90
Study 12722031 — intervention group
Group type: COMPARATOR
Intervention: Control group (no steroid treatment)
Number of subjects: 90
Study 12722031 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose prednisolone therapy
Number of subjects: 90
Study 11093446 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 12.5 mg once daily
Number of subjects: 0
Study 11093446 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib 25 mg once daily
Number of subjects: 0
Study 11093446 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibuprofen 800 mg 3 times daily
Number of subjects: 0
Study 11093446 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11093446 — intervention group
Group type: EXPERIMENTAL
Intervention: Investigator assessment
Number of subjects: 0
Study 8979658 — intervention group
Group type: EXPERIMENTAL
Intervention: Timolol maleate in solution (TS) 0.5 percent
Number of subjects: 28
Study 8979658 — intervention group
Group type: COMPARATOR
Intervention: Timolol maleate in Gelrite (TXE) 0.5 percent
Number of subjects: 28
Study 1461083 — intervention group
Group type: COMPARATOR
Intervention: MMSE scores above 25
Number of subjects: 25
Study 1461083 — intervention group
Group type: EXPERIMENTAL
Intervention: MMSE scores between 18 and 24
Number of subjects: 25
Study 1461083 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with MMSE scores
Number of subjects: 25
Study 1461083 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation with arterial blood pressure in high MMSE group
Number of subjects: 25
Study 6393316 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg daily intravenously for 2 days, then 1000 mg daily orally for 10 days in divided doses)
Number of subjects: 55
Study 6393316 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study 6393316 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine
Number of subjects: 55
Study 28214596 — intervention group
Group type: EXPERIMENTAL
Intervention: certolizumab pegol (400 mg qd reduced to 200 mg qd after one month)
Number of subjects: 382
Study 28214596 — intervention group
Group type: EXPERIMENTAL
Intervention: certolizumab pegol
Number of subjects: 382
Study 28214596 — intervention group
Group type: COMPARATOR
Intervention: methotrexate
Number of subjects: 382
Study 27235799 — intervention group
Group type: EXPERIMENTAL
Intervention: Acrolein and heptane mixture exposure
Number of subjects: 58
Study 27235799 — intervention group
Group type: COMPARATOR
Intervention: Heptane only exposure
Number of subjects: 58
Study 24823623 — intervention group
Group type: EXPERIMENTAL
Intervention: Zoster vaccine (ZV; Zostavax; Merck)
Number of subjects: 1000
Study 22901348 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine (30 mg/d, increased to a maximum of 120 mg/d)
Number of subjects: 65
Study 22901348 — intervention group
Group type: EXPERIMENTAL
Intervention: Duloxetine
Number of subjects: 65
Study 22901348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 65
Study 20455766 — intervention group
Group type: EXPERIMENTAL
Intervention: efavirenz (EFV)
Number of subjects: 227
Study 20455766 — intervention group
Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir (LPV/r)
Number of subjects: 227
Study 20455766 — intervention group
Group type: EXPERIMENTAL
Intervention: atazanavir/ritonavir (ATV/r)
Number of subjects: 227
Study 18541798 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 g of sucrose 40 minutes before exercise
Number of subjects: 6
Study 18541798 — intervention group
Group type: EXPERIMENTAL
Intervention: 37 g of sucrose 5 minutes before exercise
Number of subjects: 6
Study 18541798 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 16129987 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrathecal isobaric bupivacaine (5-12 mg) with 10 microg fentanyl and 200 microg morphine
Number of subjects: 48
Study 16129987 — intervention group
Group type: COMPARATOR
Intervention: Intrathecal isobaric bupivacaine (low doses 5-9 mg)
Number of subjects: 48
Study 12033094 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide (50% N2O + 50% O2)
Number of subjects: 48
Study 12033094 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine (mixed with propofol)
Number of subjects: 48
Study 10449123 — intervention group
Group type: EXPERIMENTAL
Intervention: Pergolide monotherapy
Number of subjects: 105
Study 10449123 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 7799707 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic hysterectomy (LH)
Number of subjects: 98
Study 7799707 — intervention group
Group type: COMPARATOR
Intervention: Vaginal hysterectomy (VH)
Number of subjects: 98
Study 2186237 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous corticosteroids
Number of subjects: 0
Study 2186237 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled corticosteroids
Number of subjects: 0
Study 2186237 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral corticosteroids (30 mg of prednisone or greater)
Number of subjects: 0
Study 2186237 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 7006303 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (0.25 mg or 0.50 mg)
Number of subjects: 60
Study 7006303 — intervention group
Group type: COMPARATOR
Intervention: Placebo (NaCl 0.9%)
Number of subjects: 60
Study 7006303 — intervention group
Group type: EXPERIMENTAL
Intervention: Low dosage atropine (0.25 mg)
Number of subjects: 60
Study 30612163 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity resistance and impact training (HiRIT)
Number of subjects: 0
Study 30612163 — intervention group
Group type: COMPARATOR
Intervention: Control group (unsupervised, low-intensity, home-based exercise)
Number of subjects: 0
Study 28581920 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide (Ca(OH)2)
Number of subjects: 100
Study 28581920 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral trioxide aggregate (MTA)
Number of subjects: 100
Study 28581920 — intervention group
Group type: COMPARATOR
Intervention: Both Ca(OH)2 and MTA
Number of subjects: 100
Study 26406065 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance training
Number of subjects: 18
Study 26406065 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight training
Number of subjects: 18
Study 26406065 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 18
Study 23961833 — intervention group
Group type: EXPERIMENTAL
Intervention: OM-plus-RMC
Number of subjects: 446
Study 23961833 — intervention group
Group type: COMPARATOR
Intervention: OM-only
Number of subjects: 446
Study 21876310 — intervention group
Group type: EXPERIMENTAL
Intervention: Cloxacillin (100 mg/mL) plus heparin (1000 IU/mL) as a 2.5-mL solution instilled in each catheter lumen after dialysis session
Number of subjects: 100
Study 21876310 — intervention group
Group type: COMPARATOR
Intervention: Heparin only
Number of subjects: 100
Study 19626504 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a regular doctor
Number of subjects: 1532
Study 19626504 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a physical in the last year
Number of subjects: 1532
Study 19626504 — intervention group
Group type: EXPERIMENTAL
Intervention: Previous physician recommendation for testing
Number of subjects: 1532
Study 19626504 — intervention group
Group type: EXPERIMENTAL
Intervention: Asking a physician for testing
Number of subjects: 1532
Study 19626504 — intervention group
Group type: COMPARATOR
Intervention: Regular doctor being a Vietnamese man
Number of subjects: 1532
Study 17440795 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic TAPP
Number of subjects: 867
Study 17440795 — intervention group
Group type: COMPARATOR
Intervention: Shouldice repair
Number of subjects: 867
Study 15502037 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenon anesthesia
Number of subjects: 40
Study 15502037 — intervention group
Group type: COMPARATOR
Intervention: Propofol anesthesia
Number of subjects: 40
Study 11922403 — intervention group
Group type: EXPERIMENTAL
Intervention: Captopril 6.25 mg
Number of subjects: 240
Study 11922403 — intervention group
Group type: COMPARATOR
Intervention: Perindopril 2 mg
Number of subjects: 240
Study 9931709 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy with cisplatinum, 5-FU and leucovorin
Number of subjects: 41
Study 9931709 — intervention group
Group type: COMPARATOR
Intervention: Etoposide, adriamycin and cisplatinum (EAP)
Number of subjects: 41
Study 8110556 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal hyoscine (loading dose 140 micrograms, followed by 5 micrograms h‐1)
Number of subjects: 40
Study 8110556 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal hyoscine
Number of subjects: 40
Study 8110556 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 3339788 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (dorsal penile nerve block)
Number of subjects: 60
Study 3339788 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 60
Study 3339788 — intervention group
Group type: COMPARATOR
Intervention: No injection (control group)
Number of subjects: 60
Study 31775402 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronidase
Number of subjects: 0
Study 31775402 — intervention group
Group type: COMPARATOR
Intervention: Other techniques
Number of subjects: 0
Study 28435117 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct continuous ICP monitoring
Number of subjects: 30
Study 25130061 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle modification (LSM)
Number of subjects: 50
Study 25130061 — intervention group
Group type: COMPARATOR
Intervention: Control (not randomized to LSM)
Number of subjects: 50
Study 25130061 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-infected subjects (all)
Number of subjects: 50
Study 25130061 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV-infected subjects
Number of subjects: 50
Study 24330906 — intervention group
Group type: COMPARATOR
Intervention: Transcranial direct current stimulation (tDCS) delivered at 1-3 mA current intensity for 20-30 minutes in once- to twice-daily sessions for up to 3 years
Number of subjects: 0
Study 24330906 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 0
Study 21745622 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% PL
Number of subjects: 75
Study 21745622 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% PL
Number of subjects: 75
Study 21745622 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 21745622 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% PL (elderly participants)
Number of subjects: 75
Study 21745622 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% PL (elderly participants)
Number of subjects: 75
Study 21745622 — intervention group
Group type: COMPARATOR
Intervention: Placebo (elderly participants)
Number of subjects: 75
Study 19423455 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional treatment plus low molecular weight heparin (LMWH) treatment (LT group, n = 135)
Number of subjects: 265
Study 19423455 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (C group, n = 130)
Number of subjects: 265
Study 17036233 — intervention group
Group type: EXPERIMENTAL
Intervention: Neurological insoles
Number of subjects: 20
Study 17036233 — intervention group
Group type: COMPARATOR
Intervention: Placebo insole
Number of subjects: 20
Study 17036233 — intervention group
Group type: COMPARATOR
Intervention: Convenient shoes without insoles
Number of subjects: 20
Study 17036233 — intervention group
Group type: COMPARATOR
Intervention: Barefoot
Number of subjects: 20
Study 15001678 — intervention group
Group type: EXPERIMENTAL
Intervention: SPECT imaging with (99m)Tc‐TRODAT‐1
Number of subjects: 78
Study 11520387 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice exercise with a single curve
Number of subjects: 246
Study 11520387 — intervention group
Group type: COMPARATOR
Intervention: Control group with two survival curves
Number of subjects: 246
Study 9684794 — intervention group
Group type: EXPERIMENTAL
Intervention: SILIMAT APTT reagent
Number of subjects: 170
Study 9684794 — intervention group
Group type: COMPARATOR
Intervention: Automated APTT (Organon‐Teknika)
Number of subjects: 170
Study 7831140 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg oral midazolam
Number of subjects: 31
Study 7831140 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5 mg/kg oral midazolam
Number of subjects: 31
Study 3365924 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release intravenous infusion system (CRIS) with 10 mL of sterile water for injection
Number of subjects: 10
Study 3365924 — intervention group
Group type: COMPARATOR
Intervention: Minibag system
Number of subjects: 10
Study 3365924 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release intravenous infusion system (CRIS) with 20 mL of D5NS as the diluent
Number of subjects: 10
Study 3365924 — intervention group
Group type: EXPERIMENTAL
Intervention: Controlled-release intravenous infusion system (CRIS) with 10 mL of 5% dextrose and 0.9% sodium chloride injection (D5NS)
Number of subjects: 10
Study 30100096 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical therapy for low back pain with or without manual therapy and exercise directed at the femoroacetabular joints
Number of subjects: 90
Study 30100096 — intervention group
Group type: EXPERIMENTAL
Intervention: Having a concurrent hip problem
Number of subjects: 90
Study 30100096 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower body mass index ≤25.4
Number of subjects: 90
Study 30100096 — intervention group
Group type: EXPERIMENTAL
Intervention: Irritable condition
Number of subjects: 90
Study 30100096 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline NPRS score of 4 points or less
Number of subjects: 90
Study 26959198 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aspirin (81 mg, n=615)
Number of subjects: 1228
Study 26959198 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n=613)
Number of subjects: 1228
Study 25575220 — intervention group
Group type: EXPERIMENTAL
Intervention: ReJoyce Arm and Hand Function Test (RAHFT)
Number of subjects: 13
Study 23010882 — intervention group
Group type: EXPERIMENTAL
Intervention: Desvenlafaxine 100 mg/day
Number of subjects: 365
Study 23010882 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 365
Study 20859299 — intervention group
Group type: EXPERIMENTAL
Intervention: Tocotrienol-rich fraction (TRF) 400 mg daily
Number of subjects: 0
Study 20859299 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 18060999 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic treatment for atrial fibrillation
Number of subjects: 0
Study 18060999 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical or pharmacologic cardioversion
Number of subjects: 0
Study 18060999 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombotic therapy
Number of subjects: 0
Study 12056783 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional regimen with insulin-like growth factor-1
Number of subjects: 24
Study 12056783 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional regimen with transthyretin
Number of subjects: 24
Study 12056783 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional regimen with retinol binding protein
Number of subjects: 24
Study 12056783 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrogen balance
Number of subjects: 24
Study 9793770 — intervention group
Group type: COMPARATOR
Intervention: OBF tonograph version 8.2
Number of subjects: 194
Study 9793770 — intervention group
Group type: COMPARATOR
Intervention: OBF tonograph version 11.2
Number of subjects: 194
Study 8080680 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (cyclophosphamide, doxorubicin, 5‐fluorouracil)
Number of subjects: 414
Study 8080680 — intervention group
Group type: COMPARATOR
Intervention: Adjuvant chemotherapy after primary irradiation +/‐ surgery
Number of subjects: 414
Study 8080680 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 414
Study 8080680 — intervention group
Group type: COMPARATOR
Intervention: Primary irradiation (55 Gy)
Number of subjects: 414
Study 2925456 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftriaxone (1 g, intravenous administration, 30 to 60 minutes preoperatively)
Number of subjects: 103
Study 923513 — intervention group
Group type: EXPERIMENTAL
Intervention: EMG feedback
Number of subjects: 24
Study 923513 — intervention group
Group type: EXPERIMENTAL
Intervention: Alpha feedback
Number of subjects: 24
Study 923513 — intervention group
Group type: COMPARATOR
Intervention: Joked control group
Number of subjects: 24
Study 923513 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 24